Batch-certified botanical ingredients distilled in accordance with GMP, ISO 9001, and international pharmacopeia standards.
A rigorous review of eugenol mechanisms, dental biomaterial integration, and Chinese industrial manufacturing advantages.
Clove essential oil (distilled from Syzygium aromaticum) has occupied a central place in odontological treatment for centuries. In modern pharmaceutical formulation, its therapeutic efficacy is attributed to its high concentration of phenylpropanoids, predominantly eugenol (4-allyl-2-methoxyphenol), alongside β-caryophyllene and eugenyl acetate. Eugenol operates via dual distinct pathways: neuro-inhibitory anesthetic action and prostaglandin synthesis blockage.
At the neuronal level, eugenol demonstrates significant voltage-gated sodium channel (VGSC) blockade across dental pulp sensory neurons. Through binding to transient receptor potential vanilloid-1 (TRPV1) receptors and subsequently desensitizing them, eugenol restricts the transmission of nociceptive signals along A-delta and C nerve fibers located within the dentinal tubules. Concurrently, it acts as an effective inhibitor of cyclooxygenase-2 (COX-2), directly reducing the concentration of inflammatory prostaglandins at the pulpal or periodontal site. This mechanistic action makes high-purity clove oil an indispensable, clean-label active ingredient in modern endodontic temporary dressings, periodontic gels, and OTC topical toothache liquids.
Global pharmacopeias (including USP, Ph. Eur., and ChP) impose strict chromatographic parameters on clove oil intended for dental application. The eugenol assay must reliably clear 85.0% to 95.0% concentration by Gas Chromatography-Flame Ionization Detection (GC-FID) / GC-MS, with strictly limited limits on heavy metals (≤10 ppm) and non-detectable organochlorine pesticide residues.
| Test Parameter | Standard Specification | Analytical Methodology | Operational Relevance |
|---|---|---|---|
| Eugenol Assay | 85.0% - 95.0% | GC-FID / GC-MS Normalized Area | Guarantees pulpal anesthetic efficacy |
| Refractive Index (20°C) | 1.528 – 1.537 | Digital Refractometer | Verifies botanical purity & absence of adulterants |
| Relative Density (20°C) | 1.042 – 1.063 g/cm³ | Oscillating U-Tube Pycnometer | Authenticity index against synthetic dilution |
| Pesticide Multi-Residues | Below LOQ (Complies with EC 396/2005) | LC-MS/MS & GC-MS/MS | Ensures biomedical & oral safety compliance |
| Heavy Metals (Pb, As, Cd, Hg) | ≤ 10 ppm Total Cumulative | ICP-MS Matrix Analysis | Mandatory for FDA & European dental device filings |
The international market for botanical dental analgesics faces substantial operational challenges. Unethical compounding using industrial synthetic eugenol derived from petrochemical guaiacol—or diluting clove bud fractions with low-grade stem oil containing elevated terpene fractions—creates severe formulation risks for dental device and pharmaceutical manufacturers. These low-spec oils exhibit erratic crystallization profiles, accelerated oxidation, and unexpected mucosal erythema in clinical settings.
Jiangxi Baicao Pharmaceutical counteracts these vulnerabilities through a closed-loop sourcing and purification architecture. Operating out of our 28,600 m² cGMP extraction facility in Ji'an, Jiangxi, we integrate secondary vacuum fractional distillation with automated stainless-steel fractionation columns. This enables the complete isolation of eugenol fractions with custom boiling point thresholds, systematically eliminating residual volatile compounds that cause harsh sensory irritation while locking in reproducible batch-to-batch organoleptic and chromatographic indices.
Proprietary vacuum rectification lines engineered to selectively concentrate eugenol compounds up to 98% purity without thermal degradation.
Every single batch undergoes GC, HPLC, and GC-MS fingerprints in our centralized quality assurance lab before release.
Standardized export-ready hazardous and non-hazardous packaging complying with UN, IMDG, and IATA multimodal regulations.
Bridging traditional botanical pharmacology with high-throughput industrial procurement and downstream formulation.
Primary chemical additive in endodontic sealer cements, temporary crowns, and cavity base liners, facilitating secondary dentin formation through controlled sedative release.
Clean-label OTC emergency toothache treatments for localized periodontal swelling, alveolar osteitis (dry socket), and pulpitis pain alleviation prior to clinical intervention.
Formulated into therapeutic mouthwashes and subgingival irrigation blends to combat halitosis, inhibit biofilm aggregation, and accelerate post-operative gingival recovery.
Extensively leveraged by transnational biochemical houses for the synthesis of vanillin, food flavoring matrices, and specialty cosmetic active derivatives.
In-depth responses resolving technical qualification, QA documentation, and custom OEM manufacturing inquiries.
Explore complementary botanical formulations and active plant distillates produced inside our 12 GMP production lines.
Direct factory supply of pharmaceutical eugenol, endodontic grade clove distillates, and OEM dental care packaging. Obtain batch analysis certificates, technical dossiers, and volume quotes within 24 hours.